Work
Pharmaceutical master service agreements almost always restrict publicity. Where a client has approved disclosure we name them. Where they have not, the engagement is described without identifying detail, and named references are available under NDA.
In short
Hibridge has delivered marketing, launch, congress and commercial analytics programmes for pharmaceutical companies operating in Egypt and the MENA region, including global manufacturers. Client identification and case detail are published only where the client has approved disclosure in writing.
Placeholder · Case studies in preparation. The structure below is final; the content is placeholder pending client approval.
Cardiovascular
A top-5 global pharmaceutical company
Go-To-Market & Product Launch—
PLACEHOLDER metric
—
PLACEHOLDER metric
PLACEHOLDER — the commercial problem in two sentences.
PLACEHOLDER — what was done, in three to four sentences.
PLACEHOLDER — the measurable result, with the measurement period stated.
Oncology
A global oncology manufacturer
Conference & Event Management—
PLACEHOLDER metric
—
PLACEHOLDER metric
PLACEHOLDER — the commercial problem in two sentences.
PLACEHOLDER — what was done, in three to four sentences.
PLACEHOLDER — the measurable result, with the measurement period stated.
Primary care
A multinational primary care portfolio
Pharmaceutical Marketing—
PLACEHOLDER metric
—
PLACEHOLDER metric
PLACEHOLDER — the commercial problem in two sentences.
PLACEHOLDER — what was done, in three to four sentences.
PLACEHOLDER — the measurable result, with the measurement period stated.
Multi-therapy
A regional pharmaceutical manufacturer
Business Intelligence & Analytics—
PLACEHOLDER metric
—
PLACEHOLDER metric
PLACEHOLDER — the commercial problem in two sentences.
PLACEHOLDER — what was done, in three to four sentences.
PLACEHOLDER — the measurable result, with the measurement period stated.
We will put you in touch with clients who have run the same work.